AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 59 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,000 | -90.0% | 80 | -92.9% | 0.00% | – |
| Q3 2022 | $10,000 | +100.0% | 1,129 | +41.1% | 0.00% | – |
| Q2 2022 | $5,000 | +25.0% | 800 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 800 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -20.0% | 800 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -79.2% | 800 | -78.2% | 0.00% | – |
| Q2 2021 | $24,000 | +20.0% | 3,676 | +37.7% | 0.00% | – |
| Q1 2021 | $20,000 | 0.0% | 2,670 | -24.6% | 0.00% | – |
| Q4 2020 | $20,000 | +300.0% | 3,543 | +338.5% | 0.00% | – |
| Q3 2020 | $5,000 | +25.0% | 808 | +1.0% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 800 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $23,481,000 | 0.99% |
| Cormorant Asset Management, LP | 1,000,000 | $5,940,000 | 0.23% |
| WealthTrust Axiom LLC | 22,347 | $132,000 | 0.06% |
| SECTORAL ASSET MANAGEMENT INC | 100,000 | $594,000 | 0.05% |
| Virtu Financial LLC | 24,577 | $146,000 | 0.02% |
| PDT Partners, LLC | 61,839 | $367,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 26,039 | $155,000 | 0.02% |
| MGO ONE SEVEN LLC | 10,000 | $59,000 | 0.01% |
| WINTON GROUP Ltd | 45,208 | $269,000 | 0.01% |
| Ancora Advisors LLC | 36,350 | $216,000 | 0.01% |